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ABSTRACT
Introduction: Patellofemoral pain (PFP) can cause
significant pain leading to limitations in societal
participation and physical activity. An international
expert group has highlighted the need for a
classification system to allow targeted intervention for
patients with PFP; we have developed a work
programme systematically investigating this. We have
proposed six potential subgroups: hip abductor
weakness, quadriceps weakness, patellar
hypermobility, patellar hypomobility, pronated foot
posture and lower limb biarticular muscle tightness.
We could not uncover any evidence of the relative
frequency with which patients with PFP fell into these
subgroups or whether these subgroups were mutually
exclusive. The aim of this study is to provide
information on the clinical utility of our classification
system.
Methods and analysis: 150 participants will be
recruited over 18 months in four National Health Services
(NHS) physiotherapy departments in England. Inclusion
criteria: adults 18–40 years with PFP for longer than
3 months, PFP in at least two predesignated functional
activities and PFP elicited by clinical examination.
Exclusion criteria: prior or forthcoming lower limb
surgery; comorbid illness or health condition; and lower
limb training or pregnancy. We will record medical
history, demographic details, pain, quality of life,
psychomotor movement awareness and knee
temperature. We will assess hip abductor and quadriceps
weakness, patellar hypermobility and hypomobility, foot
posture and lower limb biarticular muscle tightness.
The primary analytic approach will be descriptive. We
shall present numbers and percentages of participants
who meet the criteria for membership of (1) each of the
subgroups, (2) none of the subgroups and (3) multiple
subgroups. Exact (binomial) 95% CIs for these
percentages will also be presented.
Ethics and dissemination: This study has been
approved by National Research Ethics Service (NRES)
Committee North West—Greater Manchester North (11/
NW/0814) and University of Central Lancashire (UCLan)
Built, Sport, Health (BuSH) Ethics Committee (BuSH
025). An abstract has been accepted for the third
International Patellofemoral Pain Research Retreat,
Vancouver, September 2013.
BACKGROUND
Patellofemoral pain (PFP) can cause signiﬁcant
pain and dysfunction leading to limitations in
societal participation and physical activity.
Higher body mass indices and higher than
expected levels of disability and psychological
morbidity have been observed in patients with
PFP.1 2 A number of studies provide evidence
which challenges the common view that PFP is
a relatively trivial and self-limiting condition:
91% of patients had pain and dysfunction at a
follow-up of a minimum of 4 years following
diagnosis3; 96% reported having problems, a
mean of 4 years following diagnosis4; 73% still
had pain at an average of 5.7-year follow-up5;
and 94% had ongoing problems for on
average 16 years following diagnosis.6
It has also been reported that there is a
possibility that PFP predisposes people to
ARTICLE SUMMARY
Strengths and limitations of this study
▪ Currently the largest randomised controlled trial
sample size is 176 patients. Our target sample
size of 150 patients for this feasibility study indi-
cates the scale and ambition of our programme
of work.
▪ We have also included a comprehensive set of
psychosocial and physiological measures as
these may also help us to understand differences
between potential subgroups. Traditionally patel-
lofemoral research has focused on biomechan-
ical and to some extent pain measures and has
paid little attention to the wider holistic picture of
a patient’s discomfort.
▪ We have not included an assessment of cost or
resource use in this study. Therefore, any differ-
ence in the resource use of different subgroups
will remain unknown.
▪ Qualitative methods would enhance the investi-
gation of psychosocial aspects.
▪ The study is not longitudinal, but importantly
will provide key data to inform such studies.
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osteoarthritis in later life; Stathopulu and Baildam3
found that 45% of their patients with PFP, for whom PFP
was the ﬁrst recorded musculoskeletal problem, were
later diagnosed with other arthritic conditions. In a study
of people with knee pain aged over 50 years, it was found
that 507 (64%) had deﬁnite radiographic evidence of
patellofemoral osteoarthritis, which suggests that there
are speciﬁc degenerative processes occurring within the
patellofemoral joint, which may not be related to the
other articular components of the knee. It is unknown
how many of these patients had patellofemoral problems
when they were younger.7 Utting et al8, reported that 22%
of patients (mean age 67) undergoing unicompartmental
patellofemoral arthroplasty recalled having PFP as an
adolescent. However, a recent systematic review reported
that the link between PFP and patellofemoral osteoarth-
ritis should be interpreted with caution due to the
paucity of high-quality evidence.9
PFP is a condition commonly referred for physiother-
apy10 and PFP recently emerged as the third highest
ranked topic out of 185 in the Chartered Society of
Physiotherapy Musculoskeletal Research Priority
Project.11 In this national survey, there was 94.9% agree-
ment on the importance of PFP with respect to physio-
therapy practice, quality of care, cost-effectiveness and
public health. The mean number of National Health
Services (NHS) physiotherapy treatment sessions for
patients referred with PFP is reported as 8 with the
maximum number of sessions reported as 17.12 The
Cochrane Library lists four current reviews13–16; two with-
drawn reviews17 18 and one protocol,19 which are speciﬁc
to the conservative management of PFP. Collectively
these reviews suggest that there is a weak evidence base
for conservative management of PFP, including physio-
therapy, mainly due to the poor methodological quality
of existing studies. In 2012 we found 52 randomised con-
trolled trials (RCTs) recruiting 2667 participants that
investigated interventions for PFP, 60% reported results
that were not statistically signiﬁcant. The average sample
size was 51 participants and the largest study20 included
176 participants. As reﬂected in the number of
Cochrane reviews conservative care for PFP is diverse
and usually consists of a multimodal package of inter-
ventions. The current multimodal approach can include
a variety of muscle strengthening and stretching techni-
ques, patellar taping or bracing and foot orthotics. More
recent high-quality studies21 22 have proposed that a tar-
geted intervention approach for speciﬁc subgroups of
patients with PFP may produce improved patient out-
comes. Crossley et al21 also discuss the need for develop-
ing classiﬁcation systems of patients with PFP so that
“more speciﬁc treatment can be designed and evalu-
ated.” The idea of clinically subgrouping patients with
PFP and then delivering targeted treatment emerged
from the First International PFP Research Retreat.23
One of the questions posed, as part of the consensus-
building process, was “Where do we need to go?” The
response was “Identiﬁcation of sub-groups of people
with PFP is needed. This may be achieved through the
use of high quality Randomised Controlled Trials
(RCTs), which should only investigate a few potential
subgroups for which there is a credible rationale…High
quality RCTs for different conservative treatments (eg,
hip muscle retraining, gait re-education) are strongly
encouraged. However, these treatments should be tar-
geted to those sub-groups of people who are most likely
to beneﬁt.”23 The conference proposed three anatomic-
ally based subgroups, proximal (hip and pelvis), local
(patella and knee factors) and distal (foot and ankle).
The same proximal, local and distal subgrouping
approach was adopted by the Second International PFP
Research Retreat.24 This subgrouping provides a ration-
ale for researchers to develop targeted treatment inter-
ventions. However, until today there have been no
studies which have further investigated this premise.
Interestingly a separate process of international consen-
sus building about the future direction of research in
the ﬁeld of primary care musculoskeletal studies has
been conducted.25 This group has also highlighted the
need for future studies to adopt a subgrouping targeted
approach in order to improve our understanding of the
mechanisms underlying musculoskeletal problems to
optimise patient management. They highlight that in
previous studies the heterogeneity of patient samples
produces a small treatment effect, which masks a wide
range of individual responses leading to the conclusion
that non-pharmacological interventions in musculoskel-
etal conditions lead to little patient beneﬁt.
WORK PLAN
We have developed a work programme consisting of a
number of phases to investigate subgrouping and the
targeted intervention approach in PFP. Phase 1: was the
theoretical classiﬁcation of patients with PFP into dis-
tinct clinical groups based on clinical assessment tests,
which could be used to target intervention in clinical
practice, through the development of a clinical practice
framework. Phase 2 (the current phase): is developing
and testing the feasibility of using a clinical practice
framework to assign patients with PFP into subgroups.
Phase 3: RCT evaluating the cost-effectiveness of using
the clinical practice framework compared to usual care
to improve quality of life of patients with PFP. This will
incorporate an internal pilot study, to check assumptions
about outcome variability which will inform sample size
estimates.
Results of phase 1: identification and development of
clinical assessment tests
We have completed phase 1 of this work. This was a litera-
ture review, evidence synthesis and clinical mapping
undertaken by the targeted interventions for PFP research
team to establish supporting evidence for the existence of
subgroups. Subgroups were derived from the literature
which conformed to the following criteria: (1) they could
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potentially be identiﬁed by simple evidence-based clinical
assessment tests; (2) the tests could be used routinely by
physiotherapists in a variety of clinical practice settings
ranging from primary care facilities to tertiary teaching
hospitals; (3) minimal expertise and training was required
for competent performance of the tests; (4) any equip-
ment required for the tests needed to be low cost; (5) pub-
lished thresholds for potentially assigning patients to
subgroups had to be available; and (6) any potential sub-
group then had to be matched to a speciﬁc and credible
treatment intervention. Using the First International PFP
Research Retreat subgroups as a starting point, we found
that there was often more than one clinical problem at the
proximal, local and distal sites, and that there were also
multiple and sometimes complex clinical assessment tests
and multiple interventions. For example, a number of dif-
ferent strength factors have been proposed proximally at
the hip.26 27 Patients with proprioceptive deﬁcits have
been identiﬁed locally at the patella and knee;28 29
however, the problem with this subgroup is that as yet
there are no simple and cheap methods to accurately iden-
tify proprioceptive deﬁcit in clinical centres that do not
have access to dynamometry. Two clinical prediction rules
for the likely success of orthotic intervention have been
proposed distally at the foot and ankle; however, there is
no agreement between the two studies as to the individual
clinical items. The ﬁrst30 lists three items: forefoot valgus
alignment; great toe extension; navicular drop test and the
second31 lists four different items: age, height, worst pain
measured using a visual analogue scale; midfoot width dif-
ference from weight bearing to non-weight bearing.
Therefore, at the end of this work we have proposed six
rather than three subgroups each of which has a speciﬁc
clinical test which yields a score from which a threshold
has previously been published. The threshold scores will
be used to assign patients to subgroup membership
(ﬁgure 1). However, the literature was unable to provide
any evidence of the relative frequency with which patients
with PFP fell into each of these subgroups and whether
these subgroups were mutually exclusive. Therefore, the
next stage of our developmental work is an investigation of
the distribution of patients into the subgroups when the
clinical assessment tests and subsequent threshold scores
are applied in routine physiotherapy practice (phase 2).
This is the feasibility study which forms the basis of this
paper. The main aims of this feasibility study are to assess
the relative frequency with which patients fall into each of
the subgroups and whether or not the subgroups are
mutually exclusive. By the end of this study we would
expect to have greater clarity as to whether all, some or
none of our proposed subgroups could potentially be
useful in clinical practice to form the basis of targeted
treatment.
Phase 2: methods
Research question
Do clinically important subgroups of patients with PFP
exist?
Aim of study
To provide information on the clinical utility of sub-
grouping patients with PFP.
Study objectives
This study is designed to provide clinical evidence for
theoretically derived subgroups of patients with PFP,
which may be appropriate for targeted treatment. In this
study we will apply evidence-based routine clinical assess-
ment tests to a representative sample of patients with
PFP referred for physiotherapy in order to examine:
(1) the relative frequency with which they fall into each
of the subgroups; (2) whether the subgroups are mutu-
ally exclusive or whether, and how frequently, patients
fall into two or more subgroups; (3) whether there are
any subgroups which may not be clinically important in
the context of targeted treatment because insufﬁcient
patients fall into these subgroups; (4) whether patient
and clinical characteristics vary between the subgroups.
The collection of study data will also allow us to explore
the potential for better methods of classifying subgroups
by including patient and/or clinical characteristics or by
the use of different test thresholds.
Study design
Observational study, at one time point (start of physio-
therapy), of adults age 18–40 years with a clinical diag-
nosis of unilateral or bilateral PFP present for longer
than 3 months (for full eligibility criteria see box 1).
Setting
Four NHS physiotherapy departments in England:
Central Manchester University Hospitals NHS
Foundation Trust; Harrogate and District NHS
Foundation Trust; Lancashire Care NHS Foundation
Trust; NHS Solent.
Patient recruitment
One hundred and ﬁfty potential participants in total will
be recruited over an 18-month period across the four
collaborating centres. A research physiotherapist based
within each of the four physiotherapy departments will
check eligibility and obtain informed consent. Each
patient that agrees to take part will be assessed once
only by a research physiotherapist (one at each partici-
pating centre). The research assessment for this feasibil-
ity study will consist of two parts. Part 1: assessment of
demographic, clinical and psychosocial patient charac-
teristics which will take approximately 20 min to com-
plete (table 1). Data will be collected on characteristics
known to have an impact on outcome. These data may
help us to further understand differences between
potential subgroups or suggest new subgroups. Previous
studies have used some of these tools, however no other
study has attempted to systematically investigate psycho-
social issues in patients with PFP in the comprehensive
manner proposed here. Part 2: clinical assessment tests
which take approximately 25 min to complete (table 2).
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Thresholds, for assigning participants to subgroups, for
each test are based on normative data from healthy
populations ±1 SD (ﬁgure 1).
Clinical assessment tests
Dynamometer measurement of quadriceps muscle strength using a
Lafayette Manual Muscle Test System (range 0–136 kg):
The participant will be in a seated position and the hips
and knees ﬂexed to 90°. Muscle strength of the knee
extensors will be assessed with a portable dynamometer
mounted against a stabilisation strap positioned perpen-
dicular to the tibia just above the malleoli. The force
exerted against the dynamometer in this position will be
recorded and the moment arm of this force around the
extension/ﬂexion axis of the knee joint will be measured
using a tape measure as the distance from the level of the
dynamometer on the tibia to the centre of the knee joint
(assumed to coincide with the most prominent point on
the femoral epicondyle identiﬁed through palpation).
These two measurements will be used to calculate the
maximum knee extensor moment (Nm) during an iso-
metric maximal voluntary contraction (MVC) test as the
product of the force in Newtons (N) and moment arm in
metres (m).32
Dynamometer measurement of hip abductors muscle strength:
The participant will be in side lying with the tested leg
uppermost in the neutral anatomical position. The
participant will be asked to abduct their leg sideways (ie,
towards the ceiling) from this position; the portable dyna-
mometer mounted against a stabilisation strap will be held
perpendicular to the side of the leg at a level just above
the knee joint. To ensure that abductor muscle strength is
tested and that the lower limb does not rotate externally,
the participants will be instructed to ensure their toes are
pointed horizontally during the contraction. The force
exerted against the dynamometer in this position will be
recorded and the moment arm of this force around the
adduction/abduction axis of the hip joint will be mea-
sured using a tape measure as the distance from the level
of the dynamometer on the thigh to the centre of the hip
joint. These two measurements will be used to calculate
the maximum hip abductor moment (Nm) during an
MVC test as the product of the force (N) and moment
arm (m).32 Strength testing will be performed to assess
functional capacity, in particular we are interested in the
relative balance between the quadriceps and hip abduc-
tors. This simple clinical test procedure will not enable the
peripheral and central components of muscle dysfunction
to be identiﬁed but will provide a useful indication of con-
tractile performance.
Patellar glide: With the participants in supine, the quad-
riceps muscles relaxed and the knees in extension, the
clinician will apply a medially and then a laterally direc-
ted force to the patella. The total displacement of the
Figure 1 Targeted interventions for patellofemoral pain groups.
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pole of the patella will be recorded in millimetres in the
coronal plane.33
Passive knee extension (Hamstrings length): The partici-
pant will be positioned supine on a plinth. The lower
limb not being tested will be positioned in hip and knee
extension. The research physiotherapist will position the
hip and knee of the tested side in 90° of ﬂexion, thus
marking the starting position for the test. With one
hand supporting the participant’s distal thigh and the
other hand cupping the heel, the research physiotherap-
ist will passively extend the knee until ﬁrm resistance is
elicited. At this point the angle of the tibia is recorded
with a digital inclinometer.34
Passive prone knee bend (quadriceps length): The participant
will be positioned in prone lying on the edge of a plinth so
that the foot on the non-involved side will be placed on
the ﬂoor at 90° hip ﬂexion. The knee of the tested leg will
be passively maximally ﬂexed until resistance or discom-
fort is elicited. In this position the angle of the tibia will be
recorded with a digital inclinometer.33
Standing method for assessing calf ﬂexibility: The length of
the gastrocnemius muscle will be obtained by having the
participant lean on a solid support 0.6 m away with
the tested leg behind the contralateral leg and keeping the
knee of the tested leg extended. The participants will be
instructed to maximally ﬂex their tested ankle while
keeping their heel on the ﬂoor. The angle of the tibia is
recorded relative to vertical with a digital inclinometer.33
Foot posture index: There are six component assessments
(1) talar head position, (2) supralateral and infralateral
malleolar curvature, (3) calcaneal frontal plane position,
Table 1 Patient characteristics assessment
Domain Questionnaire/items
Clinical characteristics Time since onset
Previous treatment
History of trauma
Physical activity (International
Physical Activity Questionnaire
IPAQ)38
Physical functioning (Modified
Functional Index Questionnaire
(MFIQ)39
Sociodemographic
characteristics
Age
Gender
Anthropometry Height
Weight
Body mass
Leg length
Skin fold over the patellae
Psychosocial
Pain measures Nociceptive pain
Short Form McGill Pain
Questionnaire (SF-MPQ-2)40
Numeric Pain Rating Scale
(NPRS) for average pain during
the past week
Neuropathic pain
Leeds Assessment of
Neuropathic Symptoms and
Signs (S-LANSS)
Questionnaire41
Quality of life WHO Disability Assessment
Scale 2 (WHODAS 2.0)42
EQ-5D-5 L43
Hopkins Symptom Checklist 25
(HSCL-25)44
Psychomotor movement
awareness
Movement Specific
Reinvestment Questionnaire45
Physiological
parameters
Self-reported indicators of cold
knees46 skin temperature
measurement (over centre of
patella and muscle belly of
tibialis anterior)
Box 1 Eligibility criteria22–37
Inclusion criteria
Men and women aged 18–40 years able to give informed
written consent
Clinical diagnosis of unilateral or bilateral patellofemoral pain
longer than 3 months
Anterior or retropatellar pain reported on at least two of the fol-
lowing activities: prolonged sitting, ascending or descending
stairs, squatting, running, kneeling and hopping/jumping
In addition to the above, at least two of the three following clin-
ical examination findings:
▸ pain during resisted isometric quadriceps contraction
▸ pain with palpation of the posterior borders of the patella
▸ pain during squatting
Exclusion criteria
Previous knee surgery and participants awaiting surgery for
another lower limb joint problem(s)
Ligamentous instability and/or internal derangement
History of patella subluxation or dislocation
Joint effusion when the midpatellar girth is 5% or more than
the non-involved knee
True knee joint locking and/or giving way
Coexistent acute illness or chronic disease
Bursitis, patella or iliotibial tract tendinopathy,
Osgood-Schlatter’s disease, Sinding-Larsen-Johansson
Syndrome, muscle tears or symptomatic knee plicae
Participants already involved in active lower limb training
programmes
Pregnancy or breast feeding
Table 2 Clinical assessment tests
Proposed clinical groups Tests
Hip abductor weakness Hand-Held Dynamometry32
Quadriceps weakness Hand-Held Dynamometry32
Patellar hypomobility Patellar Glide Test33
Patellar hypermobility Patellar Glide Test33
Pronated foot posture Foot Posture Index35
Lower limb biarticular
muscle tightness
Rectus femoris length test33
Hamstrings length test34
Gastrocnemius length test33
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(4) prominence in the region of the talonavicular joint,
(5) congruence of the medial longitudinal arch,
(6) abduction/adduction of the forefoot on the rear-
foot. Each of the component assessments or observa-
tions are graded 0 for neutral, with scores of −2 for
clear signs of supination and +2 for clear signs of prona-
tion. Unless the criteria outlined for each of the features
are clearly met then the more conservative score will be
awarded. When the scores are combined, the aggregate
value gives an estimate of the overall foot posture. Large
positive aggregate values indicate a pronated posture.35
Training of research therapists
All research physiotherapists will undertake a full day
training session during the ﬁrst month of the study,
when they will be provided with training on the research
processes and on how to undertake the standardised
clinical assessment tests. During the training sessions, all
the therapists will be observed by the principal investiga-
tor and MC performing each of the clinical test proce-
dures and provided with peer feedback. Intertherapist
variability will be examined during these sessions and
although it will not be possible to conduct a formal
inter-rater reliability assessment during the training it
will provide an opportunity to observe any variability in
performance and address it. All the physiotherapists will
be provided with a comprehensive manual including the
standard operating procedures, along with a data record-
ing proforma.
Sample size
Given the nature of the study, power calculations are not
applicable. One hundred and ﬁfty participants will
enable us to estimate, with 95% CI, the numbers and
percentages of participants who meet the criteria for
membership of (1) each of the six subgroups individu-
ally; (2) none of the subgroups; (3) multiple subgroups
(for each represented subgroup combination) to within
±7.5% for well-represented (30% prevalence) subgroups
and to within ±3.5% for sparse (5% prevalence) sub-
groups (or multiple subgroups).
Analysis plan
As the main purpose of the study is to describe the dis-
tribution of patients with PFP into the different sub-
groups following application of the clinical assessment
test criteria, including whether patients meet the criteria
for multiple subgroups or fail to meet the criteria for
any of the subgroups, the primary analytical approach
will be descriptive.
We shall present numbers and percentages of partici-
pants who meet the criteria for membership of
1. Each of the six subgroups individually;
2. None of the subgroups;
3. Multiple subgroups (for each represented subgroup
combination).
Exact (binomial) 95% CIs for these percentages will
also be presented. We shall also present descriptive
statistics (mean (SD), median (IQR), count (%), as
appropriate) of the patient characteristics for each sub-
group (including the no clinical subgroup) to indicate
how these characteristics vary across subgroups. The
data will also enable some further exploratory analyses
to be performed. The nature of these analyses will
depend on the patterns of the distribution of partici-
pants into subgroups. However, we expect that they will
include an exploration of the sensitivity of the distribu-
tion of subgroup membership to the choices of thresh-
olds, particularly if substantial numbers of patients fall
into either multiple subgroups or no subgroup; they are
also likely to include explorations of the joint effects of
patient characteristics on the distribution of patients
into subgroups, using techniques including multiple
logistic regression. Demographic, clinical and psycho-
social characteristics as previously described may also be
included as covariates in later exploratory model-based
analyses.
DISCUSSION
Recent literature has strongly promoted the idea of sub-
grouping patients with PFP and delivering targeted treat-
ment, as it is believed that this may be more beneﬁcial
than the current multimodal therapeutic approaches.20–22
Despite these recommendations, this premise has not yet
been investigated. The main aims of this feasibility study
are therefore to assess the relative frequency with which
patients fall into each of the subgroup and whether or not
the subgroups are mutually exclusive.
As outlined above, the study has a number of strengths
and addresses key gaps in current knowledge. It is ambi-
tious in terms of scale and scope. There is often contro-
versy and lack of consensus within the ﬁeld of
patellofemoral research, due to two related factors asso-
ciated with the nature of the current evidence base.
First, there are a relatively large number of normative
data; studies conducted on very small samples of healthy
participants that do little to enhance our understanding
of this complex chronic condition.36 Second, as already
discussed, there is a limited number of high-quality,
large scale clinical trials. Set against this context, where
currently the largest RCT sample size is 176 patients,20
our target sample size of 150 patients for this feasibility
study indicates the scale and ambition of our pro-
gramme of work. In terms of the scope of this study, we
have also included a comprehensive set of psychosocial
and physiological measures as these may also help us to
understand differences between potential subgroups.
Traditionally, patellofemoral research has focused on
biomechanical and to some extent pain measures and
has paid little attention to the wider holistic picture of a
patient’s discomfort. One study has indicated that psy-
chological morbidity may be important in PFP.2 The
more comprehensive data being obtained in the present
study will provide us with a unique insight into the
patient’s experience of the condition which may also
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help further our understanding of future treatment
options. There are also potential limitations in the scope
of this study. We have not included an assessment of cost
or resource use in this study. Therefore, any differential
in the resource use of different subgroups will remain
unknown; we plan to address this in phase 3 of our pro-
gramme of work. In the current feasibility study, there is
however, a health economics component as we are col-
lecting EQ-5D-5L data so we will gain some insight into
the potential health consequences of different sub-
groups. Qualitative methods would enhance the investi-
gation of psychosocial aspects. We envisage using mixed
methods, as well as more patient and public involvement
in subsequent studies. The study is not longitudinal, but
importantly will provide key data to inform such studies.
The results of the present study are expected in 2014.
They will provide answers to a number of questions
about the validity and relevance of subgrouping in PFP
in clinical practice and will inform future trials.
Status
The study has currently recruited 101/150 patients and
is scheduled to be completed by 29 November 2013.
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